Carlo Gambacciani

Livorno, Italy

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 21 publications

Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring.

Beyond the Brain: Circulating Tumor Cells as a Tool for Diagnosis and Monitoring.

Journal: JCO precision oncology
Published: July 23, 2026

BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.

BIRC3/CAV1 co-expression drives GBM aggressiveness as a prognostic signature and therapeutic vulnerability.

Journal: Cell death discovery
Published: November 26, 2025

Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma.

Prognostic impact of circulating vitamin D and genetic variants in the vitamin D pathway in glioblastoma.

Journal: Neuro-oncology advances
Published: October 17, 2025

Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early.

Corrigendum: Metabolic-imaging of human glioblastoma live tumors: a new precision-medicine approach to predict tumor treatment response early.

Journal: Frontiers in oncology
Published: March 05, 2025

Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures.

Exploring Extracellular Vesicle Surface Protein Markers Produced by Glioblastoma Tumors: A Characterization Study Using In Vitro 3D Patient-Derived Cultures.

Journal: Cancers
Published: September 28, 2024

Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling.

Exploring Regorafenib Responsiveness and Uncovering Molecular Mechanisms in Recurrent Glioblastoma Tumors through Longitudinal In Vitro Sampling.

Journal: Cells
Published: February 07, 2024

O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients.

O-(2-18F-fluoroethyl)-L-tyrosine (18F-FET) PET as a potential selection tool for second surgery in glioblastoma patients.

Journal: Journal of neurosurgical sciences
Published: December 21, 2023

Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status.

Innovative Approach to Isolate and Characterize Glioblastoma Circulating Tumor Cells and Correlation with Tumor Mutational Status.

Journal: International journal of molecular sciences
Published: May 15, 2023

Surgical management of skull base meningiomas and vestibular schwannomas.

Surgical management of skull base meningiomas and vestibular schwannomas.

Journal: Current opinion in oncology
Published: September 12, 2022

Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early.

Metabolic-imaging of human glioblastoma live tumors: A new precision-medicine approach to predict tumor treatment response early.

Journal: Frontiers in oncology
Published: June 15, 2022

Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background.

Single-Cell Molecular Characterization to Partition the Human Glioblastoma Tumor Microenvironment Genetic Background.

Journal: Cells
Published: March 04, 2022

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Impact of recurrence pattern in patients undergoing a second surgery for recurrent glioblastoma.

Journal: Acta neurologica Belgica
Published: March 28, 2021
Showing 1-12 of 21

Last Updated: 09/26/2026